• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾去神经术的病理生理学:从肾神经解剖到程序参数。

Pathophysiology of renal denervation procedures: from renal nerve anatomy to procedural parameters.

机构信息

Deutsches Herzzentrum und 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, Munich, Germany.

出版信息

EuroIntervention. 2013 May;9 Suppl R:R89-95. doi: 10.4244/EIJV9SRA15.

DOI:10.4244/EIJV9SRA15
PMID:23732162
Abstract

Endovascular renal denervation techniques have been clinically adopted for the treatment of resistant arterial hypertension with great success. Despite the favourable early results achieved with this technology, a clear understanding of the pathophysiology underlying this novel treatment is lacking. In addition, non-responsiveness to renal denervation remains a nidus for treatment failure in distinct patients. In search of meaningful surrogate parameters relating to treatment responsiveness, the current article reviews the existing knowledge on renal nerve anatomy, changes occurring after denervation and procedural parameters collected during denervation. From preclinical experience, the most reliable morphological parameter reflecting successful renal denervation is the presence of axonal degeneration. Most procedural and clinical parameters need extended investigation before adopting them as potential surrogate parameters for successful renal denervation. As a consequence, there is an imperative need for dedicated research revealing the pathophysiology of renal denervation procedures. In this regard, close co-operation of engineers, researchers and clinicians is warranted to turn renal denervation into a milestone treatment of arterial hypertension.

摘要

血管内去肾神经术已被临床用于治疗难治性动脉高血压,并取得了巨大成功。尽管这项技术的早期结果令人满意,但对这种新疗法的病理生理学基础仍缺乏清晰的认识。此外,去肾神经术的无反应性仍然是某些患者治疗失败的根源。为了寻找与治疗反应相关的有意义的替代参数,本文综述了目前关于肾神经解剖、去神经后发生的变化以及去神经过程中收集的程序参数的知识。从临床前经验来看,反映去肾神经术成功的最可靠形态学参数是轴突变性。大多数程序和临床参数在被采纳为成功去肾神经术的潜在替代参数之前,需要进一步的研究。因此,迫切需要开展专门的研究来揭示去肾神经术的病理生理学。在这方面,工程师、研究人员和临床医生之间的密切合作是必要的,以使去肾神经术成为治疗动脉高血压的一个里程碑。

相似文献

1
Pathophysiology of renal denervation procedures: from renal nerve anatomy to procedural parameters.肾去神经术的病理生理学:从肾神经解剖到程序参数。
EuroIntervention. 2013 May;9 Suppl R:R89-95. doi: 10.4244/EIJV9SRA15.
2
Follow-up, study design and outcome parameters.随访、研究设计和结局参数。
EuroIntervention. 2013 May;9 Suppl R:R96-100. doi: 10.4244/EIJV9SRA16.
3
Current technologies: an introduction.当前技术:简介。
EuroIntervention. 2013 May;9 Suppl R:R75-82. doi: 10.4244/EIJV9SRA13.
4
Challenging anatomy, how to treat or not to treat?极具挑战性的解剖结构,是否治疗?如何治疗?
EuroIntervention. 2013 May;9 Suppl R:R67-74. doi: 10.4244/EIJV9SRA12.
5
Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.难治性高血压与肾交感神经去神经支配:药物依从性及血压降低效果的巩固
EuroIntervention. 2013 May;9 Suppl R:R7-9. doi: 10.4244/EIJV9SRA1.
6
Expanding the indication spectrum: renal denervation in diabetes.扩大适应证谱:糖尿病中的肾脏去神经支配。
EuroIntervention. 2013 May;9 Suppl R:R117-21. doi: 10.4244/EIJV9SRA20.
7
Renal denervation: a plea for wisdom.肾去神经支配:呼吁明智之举。
Arch Cardiovasc Dis. 2013 Mar;106(3):121-3. doi: 10.1016/j.acvd.2013.02.002. Epub 2013 Mar 27.
8
Endovascular treatment of resistant and uncontrolled hypertension: therapies on the horizon.血管内治疗抵抗性和不可控性高血压:即将出现的治疗方法。
JACC Cardiovasc Interv. 2013 Jan;6(1):1-9. doi: 10.1016/j.jcin.2012.09.005. Epub 2012 Dec 19.
9
Renal denervation in the treatment of drug-resistant hypertension: current knowledge and future perspectives.肾去神经术治疗耐药性高血压:现有知识和未来展望。
Expert Rev Med Devices. 2013 Mar;10(2):247-56. doi: 10.1586/erd.13.1.
10
Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.第二代EnligHTN™肾去神经支配系统在耐药性、未控制高血压患者中的安全性和性能。
Atherosclerosis. 2017 Jul;262:94-100. doi: 10.1016/j.atherosclerosis.2017.04.022. Epub 2017 May 3.

引用本文的文献

1
Renal Denervation After USA FDA Approval: An Update from an Interventional Cardiologist's Perspective.美国食品药品监督管理局(FDA)批准后的肾去神经支配:介入心脏病专家视角的最新进展
J Clin Med. 2025 May 19;14(10):3554. doi: 10.3390/jcm14103554.
2
A Perspective on the Delivery of Renal Denervation Therapy Based on Pre-Clinical Data.基于临床前数据的肾去神经支配治疗的实施前景
JACC Basic Transl Sci. 2016 Jun 27;1(4):288-295. doi: 10.1016/j.jacbts.2016.03.010. eCollection 2016 Jun.